ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Nymox Pharmaceutical Corp (QB)

Nymox Pharmaceutical Corp (QB) (NYMXF)

0.072
-0.0031
(-4.13%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
0.072
Bid
0.07
Ask
0.1149
Volume
4,211
0.0712 Day's Range 0.0998
0.0001 52 Week Range 1.40
Market Cap
Previous Close
0.0751
Open
0.0751
Last Trade
100
@
0.072
Last Trade Time
Financial Volume
$ 316
VWAP
0.07496
Average Volume (3m)
16,232
Shares Outstanding
94,540,140
Dividend Yield
-
PE Ratio
-4.21
Earnings Per Share (EPS)
-0.05
Revenue
-
Net Profit
-4.49M

About Nymox Pharmaceutical Corp (QB)

Sector
Chemicals & Chem Preps, Nec
Industry
Chemicals & Chem Preps, Nec
Website
Headquarters
Nassau, Bhs
Founded
-
Nymox Pharmaceutical Corp (QB) is listed in the Chemicals & Chem Preps sector of the OTCMarkets with ticker NYMXF. The last closing price for Nymox Pharmaceutical (QB) was $0.08. Over the last year, Nymox Pharmaceutical (QB) shares have traded in a share price range of $ 0.0001 to $ 1.40.

Nymox Pharmaceutical (QB) currently has 94,540,140 shares outstanding. The market capitalization of Nymox Pharmaceutical (QB) is $7.10 million. Nymox Pharmaceutical (QB) has a price to earnings ratio (PE ratio) of -4.21.

NYMXF Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.00906-11.17690599560.081060.09980.0712168470.07985538CS
40.009415.01597444090.06260.1050.051148340.08348113CS
12-0.054-42.85714285710.1260.14950.051162320.0886033CS
26-0.068-48.57142857140.140.14970.051194440.09877069CS
52-0.076-51.35135135140.1481.40.0001185660.10303162CS
156-0.048-400.121.40.0001360210.58189025CS
260-0.048-400.121.40.0001360210.58189025CS

NYMXF - Frequently Asked Questions (FAQ)

What is the current Nymox Pharmaceutical (QB) share price?
The current share price of Nymox Pharmaceutical (QB) is $ 0.072
How many Nymox Pharmaceutical (QB) shares are in issue?
Nymox Pharmaceutical (QB) has 94,540,140 shares in issue
What is the market cap of Nymox Pharmaceutical (QB)?
The market capitalisation of Nymox Pharmaceutical (QB) is USD 7.1M
What is the 1 year trading range for Nymox Pharmaceutical (QB) share price?
Nymox Pharmaceutical (QB) has traded in the range of $ 0.0001 to $ 1.40 during the past year
What is the PE ratio of Nymox Pharmaceutical (QB)?
The price to earnings ratio of Nymox Pharmaceutical (QB) is -4.21
What is the reporting currency for Nymox Pharmaceutical (QB)?
Nymox Pharmaceutical (QB) reports financial results in USD
What is the latest annual profit for Nymox Pharmaceutical (QB)?
The latest annual profit of Nymox Pharmaceutical (QB) is USD -4.49M
What is the registered address of Nymox Pharmaceutical (QB)?
The registered address for Nymox Pharmaceutical (QB) is BAY & DEVEAUX STS., 2ND FLOOR, NASSAU, H4M 2V2
What is the Nymox Pharmaceutical (QB) website address?
The website address for Nymox Pharmaceutical (QB) is www.nymox.com
Which industry sector does Nymox Pharmaceutical (QB) operate in?
Nymox Pharmaceutical (QB) operates in the CHEMICALS & CHEM PREPS, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RGFCReal Good Food Company Inc (CE)
$ 0.075
(74,900.00%)
517
SDCCQSmileDirectClub Inc (CE)
$ 0.0002
(19,900.00%)
117.55k
PROCFProcaps Group SA (CE)
$ 1.45
(14,256.44%)
100
AAPJAAP Inc (CE)
$ 0.0001
(9,900.00%)
1M
ZPTAZapata Computing Holdings Inc (CE)
$ 0.0001
(9,900.00%)
1.63k
ANDRAndrea Electronics Corporation (CE)
$ 0.000001
(-99.67%)
100
ANGCFEon Lithium Corporation (PK)
$ 0.0036
(-99.64%)
210
CRTLCartel Blue Inc (CE)
$ 0.0002
(-99.60%)
902
KLGGKlegg Electronics Inc (CE)
$ 0.000001
(-99.00%)
10.56k
VAXXVaxxinity Inc (CE)
$ 0.0001
(-99.00%)
10.95k
GTCHGBT Technologies Inc (PK)
$ 0.0003
(-11.76%)
723.24M
CYBLCyberlux Corp New (PK)
$ 0.0129
(50.00%)
353.76M
TONRTonner One World Holdings Inc (PK)
$ 0.0003
(50.00%)
298.57M
PSWWPrincipal Solar Inc (PK)
$ 0.0004
(0.00%)
265.01M
HMBLHUMBL Inc (PK)
$ 0.00025
(-16.67%)
262.04M

NYMXF Discussion

View Posts
Renee Renee 2 years ago
NYMX changed to NYMXF. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
👍️0
Triple nickle Triple nickle 2 years ago
Picked up some
👍️0
Spicknspan Spicknspan 2 years ago
A one time injectable treatment for an enlarged prostate would have a huge market. Bought a few here so I know I will keep an eye on the news.
👍️0
Suds Mackenzie Suds Mackenzie 3 years ago
NDA not coming soon?
👍️0
Suds Mackenzie Suds Mackenzie 3 years ago
NDA Coming soon?
👍️0
Suds Mackenzie Suds Mackenzie 3 years ago
Up today on NO news?
👍️0
Suds Mackenzie Suds Mackenzie 3 years ago
Delays and more delays and now more dilution. $.50 coming soon.
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
Will NYMX file NDA by 9/15/21?
👍️0
lytnup lytnup 4 years ago
Less than a month away.

Nymox Announces Date for Fexapotide Filing
NEWS RELEASE
HASBROUCK HEIGHTS, NJ (May 6, 2021) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it will be filing for marketing approval of Fexapotide Triflutate for BPH before the end of the summer, on or before 15 September 2021.
CEO Dr Paul Averback said, "The Company will file on or before September 15. We hope but cannot be certain that the date may be before September. Company management will communicate updates where appropriate."

https://nymox.com/files/download/45b2b195922068b
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
2ND QUARTER RESULTS DISSAPOINTING AS USUAL. STILL NO UPDATES ON NDA.
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
NDA appication coming soon? I have my doubts.
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
Now what?
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
Director - James G Robinson just picked up 38,000 shares. This was his first purchase in over a 1 1/2 years and he now owns 3,550,550 shares. He has done this many times and usually buys when it drops to around $2 or less. He is 85 years old now and God Bless he lives long enough to see this drug get FDA approval and come to market.
👍️0
stillchillin stillchillin 4 years ago
Who is buying today?? Is it GR loading up in front of good news? He has a boat load and has been holding for a while
👍️0
wesley_ wesley_ 4 years ago
$2.48 picked some up
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
Good news or bad? The clock is ticking!
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
Going down down down down down!
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
ANOTHER NICE DAY!
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
BIG NEWS COMING IN Q1.
👍️0
Suds Mackenzie Suds Mackenzie 4 years ago
Yawn
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
NDA - Ist quarter 2021, could it finally happen?
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Big news coming soon?
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
The year is almost over and still no significant news!
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
What is taking so long???
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
NDA NDA NDA NDA ?
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Even more dilution???
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
NEWS TODAY. GOOD, BAD OR SAME OLD SAME OLD.
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
More dilution - $12,000,000 stock offering.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82880626/prospectus-filed-pursuant-to-rule-424b5-424b5
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Starting to turn Bearish on this.
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Will NYMX ever succeed?
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
NDA ?? I will believe it when I see it.
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Dog and pony show continues.
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Tick Tick Tick....
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Hopefully good news coming soon.
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
What's the holdup?
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
$12,000,000. STOCK OFFERING.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82306706/securities-registration-foreign-private-issuer-f-3
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Even the Coronavirus can't keep NYMX down.
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Hope this drops under $2, I will stock up.
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Lots of news lately. Hoping for the NDA soon.
👍️0
tayronachan tayronachan 5 years ago
But will they have anything to offer in helping stop the new corona virus, or helping the victims?
Any of this?..........."The Company has research interests in protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, morphology, and drug screening design, assays, and development. Nymox maintains an active interest in scientific collaborations and has a lengthy history of working together with prominent researchers around the world."
👍️0
zumantu zumantu 5 years ago
Boom?
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Tick, tick, tick, tick.
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Report...
👍️0
yankees18 yankees18 5 years ago
Took some
👍️0
Suds Mackenzie Suds Mackenzie 5 years ago
Happy New Year for NYMX.
👍️0
Suds Mackenzie Suds Mackenzie 6 years ago
Fraud, Failure or Look for NDA in 2020
👍️0
Suds Mackenzie Suds Mackenzie 6 years ago
As at November 15, 2019, 69,968,706 common shares without par value of the Corporation were outstanding.
👍️0
Suds Mackenzie Suds Mackenzie 6 years ago
RESULTS FORTHCOMING.
👍️0
Suds Mackenzie Suds Mackenzie 6 years ago
2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
👍️0
zumantu zumantu 6 years ago
Did I miss the big news?
👍️0

Your Recent History

Delayed Upgrade Clock